Heart Calcium Scans Most Useful for Borderline Risk Patients
New research narrows ideal candidates for coronary artery calcium testing.
1The Growing Popularity of Calcium Scans
Coronary artery calcium scans are increasingly used to assess heart disease risk through CT imaging. These relatively inexpensive tests measure calcium buildup in heart arteries, with higher scores indicating greater future cardiovascular risk. The scans have become more accessible, costing between $100-$400 in the U.S. However, new Northwestern Medicine research suggests their benefits may be limited to specific patient groups rather than the general population.
2Comparing Two Risk Assessment Methods
The study compared the PREVENT calculator (using standard health metrics like blood pressure and cholesterol) against calcium scans in over 6,000 adults. PREVENT estimates 10-30 year cardiovascular risk with 73% accuracy. Adding calcium scores only improved prediction to 75% overall. This modest 2% increase suggests scans may not benefit everyone equally, challenging current widespread screening practices.
3Key Findings for Borderline Patients
Scans proved most valuable for patients initially classified as borderline/intermediate risk (3-9% 10-year risk). In this group, calcium scores better distinguished who would actually develop cardiovascular disease. About 10% of U.S. adults 30-79 have cardiovascular conditions, making accurate risk stratification crucial for preventive treatment decisions like statin prescriptions.
4Potential Downsides of Overuse
Lead author Dr. Nilay Shah warns against unnecessary scans for low/high-risk groups. Low-risk patients face radiation exposure and costs without clear benefits. High-risk patients would receive statins regardless of scan results. The study found 6% of participants experienced heart attacks/strokes during the decade-long observation period, validating PREVENT's baseline effectiveness.
5Technical Performance Metrics
The research quantified improvements using statistical discrimination measures. PREVENT alone achieved a 0.73 C-statistic (perfect prediction=1.0). Adding calcium scores increased this to just 0.75 overall. However, the improvement was more clinically meaningful for borderline cases, helping reclassify 15-20% of these patients into more accurate risk categories.
6Demographic Considerations
Participants aged 45-79 were followed in the Multi-Ethnic Study of Atherosclerosis. Researchers note need for further studies in younger populations and higher-risk ethnic groups like South Asians. Current findings may not generalize to these demographics. The study was published in JAMA and funded by NIH/NHLBI grants totaling millions in research investment.
7Clinical Practice Implications
Results support selective rather than routine calcium scan use. Shah emphasizes scans should guide treatment only when they meaningfully alter risk assessment. For many patients, traditional risk factors provide sufficient information. The findings help optimize $3.8 billion annual U.S. cardiovascular preventive care spending by reducing unnecessary testing.
8Future Research Directions
While validating PREVENT's effectiveness, researchers call for studies on calcium scoring's value in specific subpopulations. Ongoing work will examine cost-effectiveness across demographics and refine guidelines. As cardiovascular disease remains America's leading cause of death (650,000 annual deaths), such precision medicine approaches could save thousands of lives through better prevention targeting.